Hypothalamic/Pituitary Hormones Flashcards
what receptors are activated by growth hormone
JAK/STAT superfamily
what receptors are activated by prolactin
JAK/STAT
what receptors are activated by TSH
GPCR
what receptors are activated by FSH
GPCR
what receptors are activated by LH
GPCR
what receptors are activated by ACTH
GPCR
what is the primary target of GHRH?
Growth hormone –> IGF-1 (mediates most of response)
acts on liver, muscle, bone, kidney
**notably also acts on some insulin receptors - causing insulin like effects
what are the effects of GH on GFR, insulin and adipocytes?
increase GFR
anti-insulin: decrease glucose utilization, inc lipolysis - receptors become unresponsive with long term use of GH d/t overproduction of insulin – NIDDM like state
stimulate pre-adipocyte differentiation into adipocytes
somatropin vs somatrem?
somatropin = recombinant GH
somatrem = GH analog
use of recombinant GH
peds patients with:
- GH deficient
- chronic renal failure
- Noonan syndrome
- Prader Wili
- Turner
- idiopathic short stature
GH deficient in adults
Wasting in HIV pt
Short bowel syndrome
Recombinant GH AE
scoliosis during rapid growth
- hypothyroidism
- intracranial HTN - fatal AE (can increase CSF production)
- otitis media - in Turner pt
- pancreatitis, gynecomastia, nevus growth
- diabetic syndrome with chronic use
Adult AE:
- peripheral edema, myalgias, carpal tunnel syndrome
- peripheral retinopathy
Recombinant GH contraindication
p450 inducer
pt with malignancy = may increase growth of tumor
Mecasermin
IGF-1 analog
recombinant IGF-1 and human IGF-binding protein 3
Mecasermin use
mutated GH-R, neutralizing GH antibodies
mecasermin AE
hypoglycemia - eat before/after to counter AE
intracranial HTN
elevated liver enzymes
treatment for GH secreting tumors
seen as acromegaly or gigantism (if occurs in childhood)
1) GH-r antagonist
2) somatostatin analog
3) dopamine-r agonist
Pegvisomant
GH-r antagonist
prevent dimerization of receptor - still allows for receptor binding
ocreotide
somatostatin analog
ocreotide MOA
inhibits release of GH, TSH, glucagon, insulin, gastrin
- more potent than somatostatin**
ocreotide AE
n/v cramps, steatorrhea
constipation
biliary sludge/gallstones
bradycardia
B12 deficiency - w/long term use
pain at injection site
bromocriptine
dopamine agonist
cabergoline
dopamine agonist
use of bromocriptine/cabergoline
adenomas that secrete excess prolactin
*oral/vaginal insert
bromocriptine/cabergoine use
hyperprolactinemia
acromegaly
bromocriptine/cabergoline aE
nausea, headache, lightheadedness, orthostatic hypotension
(bromocriptine»cabergoline)
psych manifestations
high dose - cold induced peripheral vasospasms
pulmonary infiltrates with high dosage